Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia

NCT00270530 is registered in ClinicalTrials.gov with Center for International Health and Development as lead sponsor.

NCT NCT00270530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00270530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia
Lead sponsor
Center for International Health and Development
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2002
Completion date
October 31, 2004
Enrollment
454
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, neonatal deaths, placental malaria infection, prematurity, stillbirth